These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20564810)

  • 1. HIV clinic gets ART to toughest cases. Patients with 10-plus meds targeted.
    AIDS Alert; 2010 May; 25(5):51-3. PubMed ID: 20564810
    [No Abstract]   [Full Text] [Related]  

  • 2. How some HIV clinics handle substance abuse.
    Clements A; Gerse M; Mabry SH
    AIDS Alert; 2001 Aug; 16(8):95-7. PubMed ID: 11547704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV clinic improves medication adherence. DOT is latest experimental strategy.
    AIDS Alert; 2005 Mar; 20(3):28-9. PubMed ID: 15789471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planning for interruptions in service: expecting the unexpected.
    Valenti WM
    AIDS Read; 2005 Nov; 15(11):585-8. PubMed ID: 16329180
    [No Abstract]   [Full Text] [Related]  

  • 5. Rand Corp. study seeks participants.
    Wagner G
    Posit Living; 2001 Jan; 10(1):15. PubMed ID: 11548483
    [No Abstract]   [Full Text] [Related]  

  • 6. Do your meds play well with others? A guide to HIV drug interactions.
    Mehta S; Vázquez E
    Posit Aware; 2011; 23(2):52-5. PubMed ID: 21796852
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in HIV care, Part 2: antiretrovirals in the pipeline, HIV/hepatitis C virus coinfection, and pharmacokinetics of treatment adherence--a roundtable discussion.
    Corales RB; Djeloski DS; Mancenido MD; Valenti WM
    AIDS Read; 2009 Feb; 19(2):62-4, 70-4, 78. PubMed ID: 19271330
    [No Abstract]   [Full Text] [Related]  

  • 8. Is HIV treatment becoming too complex for nonspecialists?
    Johnston C
    CMAJ; 1998 Aug; 159(3):214. PubMed ID: 9724969
    [No Abstract]   [Full Text] [Related]  

  • 9. Adherence to complex combination antiretroviral therapies by HIV-positive drug abusers.
    Malow RM; Baker SM; Klimas N; Antoni MH; Schneiderman N; Penedo FJ; Ziskind D; Page B; McMahon R
    Psychiatr Serv; 1998 Aug; 49(8):1021-2, 1024. PubMed ID: 9712205
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: to treat or not to treat.
    Marks R
    Focus; 2002 Aug; 17(9):2. PubMed ID: 12243132
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement of the patient flow in a large urban clinic with high HIV seroprevalence in Kampala, Uganda.
    Castelnuovo B; Babigumira J; Lamorde M; Muwanga A; Kambugu A; Colebunders R
    Int J STD AIDS; 2009 Feb; 20(2):123-4. PubMed ID: 19182060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse treatment should be key component of HIV treatment plan. Experts explain some best-practice strategies.
    Agins B; Gourevitch M; Masci J; Rotheram-Borus MJ; Hitt RS; Haikalis S; Mabry SH; Gerse M
    AIDS Alert; 2001 Jul; 16(7):81-3. PubMed ID: 11548650
    [No Abstract]   [Full Text] [Related]  

  • 14. Who gets treatment and...side effects.
    TreatmentUpdate; 2002 Dec; 14(9):2-3. PubMed ID: 12593382
    [No Abstract]   [Full Text] [Related]  

  • 15. Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence.
    Taylor LE; Schwartzapfel B; Allen S; Jacobs G; Mitty J
    Clin Infect Dis; 2003 Jun; 36(11):1501-2; author reply 1502-3. PubMed ID: 12766851
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV meds: keeping trouble at bay.
    Daughtry LM; Bankston JB; Deshotels JM
    RN; 2002 Feb; 65(2):31-5; quiz 36. PubMed ID: 15328865
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV infection.
    Johnson M; Phillips A; Wilkinson D
    Clin Evid; 2002 Jun; (7):636-44. PubMed ID: 12230691
    [No Abstract]   [Full Text] [Related]  

  • 18. Directly observed antiretroviral therapy for injection drug users with HIV infection.
    Clarke S; Keenan E; Ryan M; Barry M; Mulcahy F
    AIDS Read; 2002 Jul; 12(7):305-7, 312-6. PubMed ID: 12161852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capacity of health-care facilities to deliver HIV treatment and care services, Northern Tanzania, 2004.
    Landman KZ; Kinabo GD; Schimana W; Dolmans WM; Swai ME; Shao JF; Crump JA
    Int J STD AIDS; 2006 Jul; 17(7):459-62. PubMed ID: 16820075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
    Seyler C; Anglaret X; Dakoury-Dogbo N; Messou E; Touré S; Danel C; Diakité N; Daudié A; Inwoley A; Maurice C; Tonwe-Gold B; Rouet F; N'Dri-Yoman T; Salamon R;
    Antivir Ther; 2003 Oct; 8(5):385-93. PubMed ID: 14640385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.